This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Dr. Alan Taub Joins CellEra

CAESAREA, Israel, February 11, 2013 /PRNewswire/ --

CellEra, the leading developer of cost-effective Platinum Free Fuel Cell technology has announced today that Dr. Alan Taub, professor of Materials Science and Engineeing at the University of Michigan and former General Motors Vice President Global R&D, will be joining its board of directors as an independent industry expert. Dr. Taub is a well known authority on vehicle propulsion and electrification. He joined GM as executive director in 2001 and was named vice president in 2009. Dr. Taub played a key role in the GM's fuel cell program, among the largest and most advanced in the automotive industry. Dr. Taub is a member of the U.S. National Academy of Engineering, and served on the Operating Council for the United States Council for Automotive Research. He also is chair for the Visiting Committee on Advanced Technology (VCAT) for NIST.

"We are delighted to have Dr. Alan Taub join our team," said Ziv Gottesfeld , CEO of CellEra. "His experience in leading present day fuel cell technology from prototype phase through to millions of miles logged under the hood, will be invaluable to us as we continue to advance and commercialize our Platinum Free fuel cell technology."

"While fuel cell based propulsion is now largely accepted as the only viable solution for a full-range, all-electric-drive-train vehicle, fuel cell costs, and specifically platinum price volatility, remain a major area of concern for automotive companies," said Dr. Alan Taub. "I am excited with the potential of CellEra's technology to alleviate such concerns, in automotive as well as in other market sectors, and was further impressed with the progress they have made to date. I therefore very much look forward to working with the team in bringing this technology to market."

About CellEra

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs